Vemurafenib (BRAF Inhibitor) Therapy for Orbital Erdheim-Chester Disease.

Gupta, Adit; Yeganeh, Amir; Rootman, Daniel; Goldberg, Robert

Gupta, Adit; Yeganeh, Amir; Rootman, Daniel; Goldberg, Robert.

Affiliation

Gupta A; *Stein Eye Institute, Division of Orbital and Oculoplastic Surgery, University of California, Los Angeles, and Doheny Eye Institute, Los Angeles, California, U.S.A.

Ophthalmic Plast Reconstr Surg ; 33(6): e138-e139, 2017.

Article in En | MEDLINE | ID: mdl-28099231

Subject(s)

Erdheim-Chester Disease/drug therapy; Indoles/administration & dosage; Orbital Diseases/drug therapy; Proto-Oncogene Proteins B-raf/antagonists & inhibitors; Sulfonamides/administration & dosage; Biopsy; Diagnosis, Differential; Dose-Response Relationship, Drug; Enzyme Inhibitors/administration & dosage; Erdheim-Chester Disease/diagnosis; Follow-Up Studies; Humans; Male; Middle Aged; Orbit/diagnostic imaging; Orbital Diseases/diagnosis; Rare Diseases; Tomography, X-Ray Computed; Vemurafenib

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Orbital Diseases / Sulfonamides / Erdheim-Chester Disease / Proto-Oncogene Proteins B-raf / Indoles Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Systematic_reviews Limits: Humans / Male / Middle aged Language: En Journal: Ophthalmic Plast Reconstr Surg Journal subject: OFTALMOLOGIA Year: 2017 Document type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google